Xia Sheng Selected Research

4-hydroxybenzophenone

8/2022

4-hydroxybenzophenone exposure inhibits mouse hippocampal neural stem cell proliferation in vitro by upregulating Cxcl1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xia Sheng Research Topics

Disease

34	Neoplasms (Cancer) 03/2024 - 12/2006
14	Atrial Fibrillation 12/2023 - 10/2014
10	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 03/2015
9	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 01/2012
8	Neoplasm Metastasis (Metastasis) 10/2022 - 03/2007
7	Heart Failure 12/2023 - 12/2005
6	Inflammation (Inflammations) 12/2023 - 06/2013
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 05/2012
6	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2012
4	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 06/2015
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 12/2006
3	Diabetes Mellitus 01/2023 - 08/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2012
3	Hypoxia (Hypoxemia) 12/2022 - 01/2019
3	Obesity 03/2020 - 05/2013
3	Insulin Resistance 05/2018 - 07/2013
3	Leukemia 11/2016 - 05/2012
2	Fatigue 03/2024 - 01/2024
2	Diabetes Complications 01/2023 - 01/2020
2	Triple Negative Breast Neoplasms 12/2022 - 10/2022
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2008
2	Hemorrhage 02/2021 - 11/2017
2	Fibrosis (Cirrhosis) 02/2021 - 06/2015
2	Fistula 08/2020 - 01/2020
2	Infections 03/2020 - 03/2013
2	Ganglion Cysts (Ganglion) 01/2020 - 04/2013
2	Hypertension (High Blood Pressure) 01/2020 - 10/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2018
2	Non-alcoholic Fatty Liver Disease 05/2018 - 02/2015
2	Carcinogenesis 01/2018 - 01/2012
2	Stroke (Strokes) 01/2018 - 11/2017
2	Hypertrophy 01/2017 - 01/2015
2	Chronic Disease (Chronic Diseases) 08/2016 - 08/2012
2	Infarction (Infarctions) 03/2016 - 02/2016
2	Kidney Neoplasms (Kidney Cancer) 11/2015 - 12/2014
2	Myocardial Infarction 01/2015 - 11/2009
2	Rheumatoid Arthritis 08/2012 - 01/2012
2	Chronic Obstructive Pulmonary Disease (COPD) 08/2012 - 02/2012
2	Osteoarthritis 08/2012 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2009 - 03/2007
1	Cough 12/2023
1	Cardiac Arrhythmias (Arrythmia) 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Esophageal Fistula 12/2023

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2006
5	CholesterolIBA 01/2023 - 11/2009
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 11/2009
4	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2020
4	EnzymesIBA 10/2023 - 05/2018
4	bufalinIBA 01/2021 - 01/2016
4	Messenger RNA (mRNA)IBA 06/2015 - 01/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 07/2013
3	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2012
3	Estrogens (Estrogen)FDA Link 01/2022 - 01/2015
3	AndrogensIBA 10/2015 - 03/2015
3	CytokinesIBA 02/2015 - 07/2013
2	Small Cytoplasmic RNAIBA 01/2024 - 01/2023
2	allogenic effect factor (AEF)IBA 12/2023 - 01/2020
2	Sorafenib (BAY 43-9006)FDA Link 10/2023 - 11/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 01/2023 - 01/2020
2	SurvivinIBA 12/2022 - 10/2022
2	Docetaxel (Taxotere)FDA Link 12/2022 - 10/2022
2	Carbon Tetrachloride (Tetrachloromethane)IBA 09/2022 - 06/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 12/2021
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 12/2021
2	MKC8866IBA 01/2022 - 01/2019
2	Rifaximin (L 105)FDA Link 02/2021 - 11/2015
2	Tumor Biomarkers (Tumor Markers)IBA 11/2020 - 01/2018
2	oxidized low density lipoproteinIBA 03/2020 - 11/2009
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2020 - 10/2016
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2020
2	brucineIBA 05/2018 - 01/2012
2	AnticoagulantsIBA 01/2018 - 11/2017
2	CarcinogensIBA 01/2018 - 01/2012
2	Daunorubicin (Cerubidine)FDA LinkGeneric 12/2017 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 10/2017 - 01/2008
2	CateninsIBA 10/2016 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 12/2006
2	Evans Blue (Blue, Evans)FDA Link 03/2016 - 02/2016
2	ParaffinIBA 01/2016 - 12/2006
2	Small Interfering RNA (siRNA)IBA 03/2015 - 03/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2013 - 03/2013
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2009 - 03/2007
1	Anti-Arrhythmia AgentsIBA 12/2023
1	Ethanol (Ethyl Alcohol)IBA 12/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2023

Therapy/Procedure

12	Therapeutics 01/2023 - 03/2007
10	Drug Therapy (Chemotherapy) 12/2023 - 05/2013
10	Catheter Ablation 12/2023 - 10/2014
4	Cardiac Resynchronization Therapy 01/2023 - 12/2005
4	Vagus Nerve Stimulation 02/2016 - 01/2015
3	Glycemic Control 01/2023 - 01/2020
3	Castration 01/2023 - 10/2015
2	Autogenic Training 03/2024 - 01/2024
2	Radiofrequency Ablation 01/2021 - 08/2020
1	Conscious Sedation 12/2023